Marcucci Marco Tullio received 7,500 derivative securities of AGENUS on August 5, 2026, and held 7,500 derivative securities afterward. The transaction accounted for about 100.0% of his resulting derivative-securities holding, giving investors a precise view of the position created by the award.
Key Highlights
- The filing reported the transaction under SEC transaction code A and described the event as an award of derivative securities.
- Marcucci Marco Tullio’s resulting AGENUS derivative-securities holding was 7,500.
- The award represented about 100.0% of his resulting derivative-securities position.
Marcucci Marco Tullio received 7,500 derivative securities of AGENUS (NASDAQ: AGEN) on August 5, 2026. The award left him with 7,500 derivative securities in AGENUS after the transaction.
AGENUS Derivative Securities Award Details
The resulting position was 7,500 derivative securities. The transaction represented about 100.0% of Marcucci Marco Tullio’s resulting derivative-securities holding in AGENUS. The transaction date was August 5, 2026.
FAQs
Q: What did Marcucci Marco Tullio receive from AGENUS?
A: Marcucci Marco Tullio received 7,500 derivative securities of AGENUS on August 5, 2026. The transaction was classified under code A.
Q: How large was Marcucci Marco Tullio’s resulting AGENUS holding?
A: Following the filing, his resulting position comprised 7,500 AGENUS derivative securities. The transaction represented about 100.0% of those resulting derivative securities, according to the reported Form 4.
Q: What does transaction code A mean in this AGENUS insider transaction?
A: The filing reported the transaction under SEC code A and described it as an award of derivative securities. The transaction involved Marcucci Marco Tullio, identified as an AGENUS insider.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.